Home » BG Medicine Seeks FDA Clearance for ARCHITECT Galectin-3 Assay
BG Medicine Seeks FDA Clearance for ARCHITECT Galectin-3 Assay
Cardiovascular diagnostics developer BG Medicine has filed a 510(k) premarket notification with the FDA for regulatory clearance for the ARCHITECT Galectin-3 assay.
Pharmaceutical Business Review
Pharmaceutical Business Review
Upcoming Events
-
07May
-
14May
-
30May